
Mobility & TransportationBiotech & Life SciencesAICrypto & Web3FintechHealthcareE-Commerce & Marketplace
Gaorong Capital is a venture capital firm specializing in early and growth-stage investments, primarily in China. Their investment focus spans new consumption, new technology (including AI and frontier technologies), enterprise services, and healthcare sectors, with a strong emphasis on TMT. The firm positions itself as "China's Founders' Fund," aiming to be a strategic partner for entrepreneurs driving innovation and industry transformation.
Deal activity decreased year-over-year (2 deals in the last 12 months vs 6 prior). Average disclosed round size is $221.6M (across 16 rounds with reported amounts).
Portfolio
16
Fund Size
$4B
Top Stage
Growth
Last 12 Mo
2
Team
BY
Bin Yue
Partner
JY
Jiangtao Yu
Managing Director
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
16 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| NNeolix | Series D | $600M | Oct 2025 |
| Seed | $25M | Sep 2025 | |
| PPulnovo Medical | Series C | $100M | Mar 2025 |
| HHashKey Group | Growth | $30M | Feb 2025 |
| HHashKey Group | Growth | $30M | Feb 2025 |
| AArnatar Therapeutics | Series A | $52M | Dec 2024 |
| Series A | $42M | Nov 2024 | |
| DDongchedi | Growth | $600M | Sep 2024 |
| Series B | $31M | Dec 2023 | |
| Series D | $600M | Nov 2021 | |
| Series A | $55M | Jul 2021 | |
| Series B | $120M | Nov 2019 | |
| Growth | $940M | Feb 2019 | |
| Series A | $10M | Oct 2018 | |
| PPinduoduo | Series B | $110M | — |
| SSironax | Series B | $200M | — |
Top Co-Investors
Lilly Asia Ventures2 shared
Sequoia China2 shared
Yunqi Partners2 shared
SoftBank Vision Fund2 shared
Legend Capital2 shared
General Atlantic1 shared
Hongshan1 shared
KKR & Co.1 shared
OrbiMed1 shared
LYFE Capital1 shared
K2VC1 shared
Kleiner Perkins1 shared
UpHonest Capital1 shared
Tencent Investment1 shared
Tiger Global Management1 shared
Baillie Gifford1 shared
GV (Google Ventures)1 shared
T. Rowe Price Associates, Inc.1 shared
Redpoint Ventures1 shared
Last updated: 15 April 2026